Wai Chun Bio-Technology Limited has rescheduled its extraordinary general meeting (EGM) from 20 April 2026 to 24 April 2026 at 3:00 p.m., maintaining the venue at Rooms 4001-02, 40/F, China Resources Building, 26 Harbour Road, Wan Chai, Hong Kong.
The postponement aligns with Listing Rule 13.66(1), which requires at least 10 business days’ notice before the closure of the register of members.
Correspondingly, the book closure period shifts to 21–24 April 2026 (both days inclusive). Share transfers must be lodged with Union Registrars Limited by 4:00 p.m. on 20 April 2026, and the record date for voting entitlement is set for 24 April 2026.
Proxy forms dispatched on 31 March 2026 remain valid. Shareholders intending to vote by proxy must submit forms no later than 3:00 p.m. on 22 April 2026. Any subsequently filed proxy will supersede the previous submission.
No changes have been made to the resolution outlined in the original EGM notice. The board continues to comprise Executive Director Lam Ka Chun (Chairman and CEO) and Independent Non-executive Directors Wong Po Keung, Wang Ziniu, and Xu Huiling.